Eliem Therapeutics, Inc. (ELYM)
Total Valuation
ELYM has a market cap or net worth of $91.13 million. The enterprise value is -$45.35 million.
Market Cap | 91.13M |
Enterprise Value | -45.35M |
Important Dates
The next earnings date is Monday, June 6, 2022, before market open.
Estimated Earnings Date | Jun 6, 2022 |
Ex-Dividend Date | n/a |
Share Statistics
ELYM has 26.57 million shares outstanding. The number of shares has increased by 460.40% in one year.
Shares Outstanding | 26.57M |
Shares Change (YoY) | +460.40% |
Shares Change (QoQ) | -21.33% |
Owned by Insiders (%) | 33.19% |
Owned by Institutions (%) | 72.45% |
Float | 2.21M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 0.55 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
Current Ratio | 24.58 |
Quick Ratio | 22.63 |
Debt / Equity | 0.00 |
Debt / EBITDA | 0.00 |
Debt / FCF | 0.00 |
Financial Efficiency
Return on equity (ROE) is -83.30%, which is considered low. The company has a ROIC of -79.70%.
Return on Equity (ROE) | -83.30% |
Return on Assets (ROA) | -40.30% |
Return on Capital (ROIC) | -79.70% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.41M |
Employee Count | 37 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (1Y) | n/a |
Total Price Change | -72.56% |
50-Day Moving Average | 5.50 |
200-Day Moving Average | 9.74 |
Average Volume (30 Days) | 197,398 |
Short Selling Information
The latest short interest is 1.05 million, so 3.94% of the outstanding shares have been sold short.
Short Interest | 1.05M |
Short % of Shares Out | 3.94% |
Short % of Float | 47.39% |
Short Ratio (days to cover) | 3.91 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -35.67M |
Net Income | -47.48M |
Net Income Common | -52.03M |
EBITDA | -47.48M |
EBIT | -47.48M |
Earnings Per Share (EPS) | -$2.54 |
Balance Sheet
The company has $136.48 million in cash and no debt, giving a net cash position of $136.48 million or $5.14 per share.
Cash & Cash Equivalents | 136.48M |
Total Debt | 0 |
Net Cash | 136.48M |
Net Cash Per Share | $5.14 |
Book Value | 167.20M |
Book Value Per Share | 6.29 |
Working Capital | 142.22M |
Cash Flow
Operating Cash Flow | -36.07M |
Capital Expenditures | n/a |
Free Cash Flow | -36.07M |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ELYM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -57.09% |
FCF Yield | -39.58% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -460.40% |
Shareholder Yield | -460.40% |
Analyst Forecast
The average price target for ELYM is $24.48, which is 613.70% higher than the current price. The consensus rating is "Buy".
Price Target | $24.48 |
Price Target Difference | 613.70% |
Analyst Consensus | Buy |
Analyst Count | 10 |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |